News

Tenofovir Vaginal Gel Delivers HIV Prevention


 

The study also showed no sign of tenofovir resistance in women who became infected despite use of the drug, a benign adverse effect profile, no safety issues in pregnancy, and no increase in HIV risk behavior. During the study, all women received regular counseling that reinforced the need for condom use whenever possible. The purpose of the gel was to give women protection when a condom wasn't used.

Pages

Recommended Reading

Tamoxifen and Raloxifene Hold Up as Breast Cancer Prevention
MDedge Internal Medicine
FDA Panel Urges Restrictions on Tanning Beds
MDedge Internal Medicine
NAMS Updates Statement on Hormone Therapy
MDedge Internal Medicine
Age Alters Bisphosphonates' Effect on Stenosis
MDedge Internal Medicine
Second Trimester Chemo Did Not Harm Fetus
MDedge Internal Medicine
Bariatric Surgery Cuts Pregnancy Hypertension
MDedge Internal Medicine
In Utero Alcohol Exposure Linked With Childhood AML
MDedge Internal Medicine
Early Menopause Doubles CVD Risk Later
MDedge Internal Medicine
Long-Acting Methods Are Contraception's Future
MDedge Internal Medicine
Ovarian Cancer Screen Promises Earlier Disease Detection
MDedge Internal Medicine